Overall Status

Completed (2)

Recruiting (1)

Terminated (1)

Phase

Sponsor

IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy (1)

Maastricht University (1)

McGill University Health Centre/Research Institute of the McGill University Health Centre (1)

Turkish Thoracic Society (1)

Collaborator

McGill University (1)

Universite Libre de Bruxelles (1)

Intervention

blood draws (1)

clinical data collection (1)

genetic data/dna/rna (1)

other biological samples to biobank (skin, lung and muscle biopsies; bronchoalveolar lavage (bal fluid) (1)

radiomics (1)

Study Documents

Intervention Type

diagnostic test (1)

other (1)

Funder Type

Other (4)

Study Type

Observational (2)

Observational [Patient Registry] (2)

usual interstitial pneumonia

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Interstitial Lung Disease, Systemic Autoimmune Disease, Rheumatic Diseases Trial in Montréal (Blood draws, Other biological

Recruiting

Interstitial Lung Disease
+8 more

Blood draws
+3 more

Montréal, Quebec, Canada

RI-MUHC

Sep 1, 2021

Radiomics to Classify Between Idiopathic Pulmonary Fibrosis and

Completed

Interstitial Lung Disease
+2 more

radiomics

Maastricht, Limburg, Netherlands

Maastricht University

Jun 11, 2020

Idiopathic Pulmonary Fibrosis, Usual Interstitial Pneumonia Trial in Turkey

Terminated

Idiopathic Pulmonary Fibrosis
Usual Interstitial Pneumonia

Adana, Turkey
+45 more

Sep 23, 2019

Lung Diffusing Capacity for Nitric Oxide asMarker of Fibrotic

Completed

Usual Interstitial Pneumonia
Nonspecific Interstitial Pneumonia

(no location specified)

Nov 2, 2015